Cipla share news and announcements
NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹1,338.00up ₹7.10 (0.53%)BSE ₹1,337.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,330.90.
52-week range of traded prices to 23 Oct 2026
₹1,165.70Low, 2 Apr 2026₹1,673.00High, 23 Oct 2025
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,08,093 Cr99th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 32.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.97%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 10.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 11.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,23,90058.1% delivered
Cipla share news and announcements
1,573 announcements, routine notices left out, newest first. Page 32 of 32.
Jan 2008
23 Jan · Updates
Cipla Ltd. has informed the Exchange about various periodic disclosures made to Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India. The Company has now received further demand notice from the Government demanding an amount of Rs.27.30 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period December 2003 to June 2007 in respect of the drug Ciprofloxacin. The demand is contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable.16 Jan · Board meeting
Meeting on 24 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Nov 2007
14 Nov · Miscellaneous
Cipla Ltd. has informed the Exchange about various periodic disclosures made to Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs.991.39 crores alongwith interest which according to them was allegedly overcharged by the Company till March 2007 in respect of drugs listed in the said notices. The Company has now received further demand notice where the government has demanded an amount of Rs.24.23 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period April 2006 to March 2007 in respect of the drug Ciprofloxacin. The demand is contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable.1 Nov · Miscellaneous
Cipla Ltd. has informed the Exchange about various periodic disclosures made to Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs.941.92 crores alongwith interest which according to them was allegedly overcharged by the Company till March 2006 in respect of five drugs. The Company has now received further demand notice where the government has demanded an amount of Rs.49.47 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period April 2006 to March 2007 in respect of the drug Salbutamol. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable.
Oct 2007
24 Oct · Miscellaneous
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on the Company's website www.cipla.com regarding the financial results for the period ended September 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Oct · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 109839 lacs for quarter ending on 30-SEP-2007 against Rs. 89611 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 19062 lacs for the quarter ending on 30-SEP-2007 against Rs. 18028 lacs for the quarter ending on 30-SEP-2006.16 Oct · Board meeting
Meeting on 24 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Aug 2007
28 Aug · Management
Cipla Ltd. has informed the Exchange that: "Dr. M. K. Gurjar, Director has resigned from the Board of Directors due to personal reasons with effect from August 27, 2007".27 Aug · Meeting
Cipla Ltd. has informed the Exchange regarding the resolutions passed at the Annual General Meeting of the Members of the Company held on August 24, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Aug · Miscellaneous
Cipla Ltd. has informed the Exchange that dividend warrants for the year 2006-2007 will be dated on or about August 31, 2007 and will be dispatched to the shareholders within the stipulated time limit.
Jul 2007
25 Jul · Meeting
Cipla Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on August 24, 2007.20 Jul · Miscellaneous
Cipla Ltd. has submitted to the Exchange a copy of Financial Review - Period ended June 2007 - a note displayed on the website www.cipla.com. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jul · Dividend
Cipla Ltd. has informed the Exchange that the Board of Directors at its Meeting held on July 20, 2007 declared dividend of Rs.2/- per equity share for the year ended March 31, 2007. Further, the dates of closure of Register of Members and purpose are: August 10, 2007 to August 24, 2007 for dividend and date from which the dividend is payable: On or before September 23, 2007. Further, the statement of the financial results for the year ended March 31, 2007 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jul · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 90183 lacs for quarter ending on 30-JUN-2007 against Rs. 86358 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 11976 lacs for the quarter ending on 30-JUN-2007 against Rs. 17043 lacs for the quarter ending on 30-JUN-2006.13 Jul · Board meeting
Inter-alia to consider the Annual Accounts for the year ended March 31, 2007, Recommendation of Dividend, if any and Unaudited Financial Results for the first quarter ended June 30, 2007.
Jun 2007
7 Jun · News Verification
News Verification : The media had reports that Reliance Industries Ltd may acquire a stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Cipla Ltd. has vide its letter inter-alia stated, "The Company denies the rumour appearing in the news item."
May 2007
5 May · Miscellaneous
Cipla Ltd. had informed the Exchange on May 05, 2007 that "This has reference to our letters dated 5th September 2003, 1st December 2003, 13th April, 2007 and Various periodic disclosures made to the Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs. 748.27 crores alongwith interest which according to them was allegedly overcharged by the Company till July 2003 in respect of five drugs. The Company has now received further demand notices where the Government has demanded an amount of Rs. 193.65 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period August 2003 to March 2006 in respect of the same five drugs. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable."
Apr 2007
26 Apr · Miscellaneous
Cipla Ltd. has submitted to the Exchange on April 26, 2007, a copy of Financial Review - Period ended March 2007. The details of the same shall be available, on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Apr · E-mail ID for Investor Complaints
Cipla Ltd. has informed the Exchange that "An exclusive e-mail id viz: [email protected] already exists in the Company for the purpose of redressal of investor grievances".19 Apr · Board meeting
Meeting on 26 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”13 Apr · Miscellaneous
Cipla Ltd. has informed the Exchange about various periodic disclosures made to the Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs.180.37 crores, being 50% of Rs.360.75 crores which according to them was allegedly overcharged by the Company till July 2003 in respect of five drugs.The Company has now received notices where the government has demand entire 100% of the aforesaid amount along with interest aggregating to Rs.748.27 crores. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that the notices of the government are not tenable and sustainable.
Jan 2007
23 Jan · Miscellaneous
Cipla Ltd. has submitted to the Exchange a copy of the note titled "Financial Review - Period ended December 2006". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jan · Board meeting
Meeting on 23 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”